Pliant Therapeutics Inc (PLRX)
$1.13
$-0.02
(-1.74%)
As on 28-Aug-2026 11:33EDT
Market cap
$72 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
37.31
-
EV/EBITDA
-2.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.5
-
Face value
--
-
Shares outstanding
61,921,897
7 Years Aggregate
CFO
$-371.71 Mln
EBITDA
$-393.99 Mln
Net Profit
$-370.58 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
| -7.4 | 4.6 | -8.9 | -33.1 | -58.9 | -42.5 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
| -90.7 | -27.1 | -6.3 | 43.2 | -40.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pliant Therapeutics Inc (PLRX)
|
1.1 | 71.5 | 0.0 | -92.3 | -- | -56.3 | -- | 0.5 |
| 17.6 | 6,238.0 | 3,117.6 | 157.4 | 14.7 | -- | 37.3 | 188.9 | |
| 201.0 | 10,883.2 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 130.9 | |
| 77.2 | 15,932.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 115.2 | 13,215.0 | 830.8 | 54.9 | 3.2 | 8.1 | 271.7 | 18.7 | |
| 24.2 | 11,971.8 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.8 | |
| 7.8 | 5,444.6 | 7,430.4 | 452.5 | 17.6 | 7 | 10.4 | 0.8 | |
| 281.0 | 5,707.4 | 290.5 | 197.2 | 82.5 | 19.9 | 29.6 | 5.9 | |
| 68.3 | 6,142.1 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 31.5 | |
| 145.8 | 9,129.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 20.5 |
Shareholding Pattern
View DetailsAbout Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small... molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Read more
-
President, CEO & Director
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
-
President, CEO & Director
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
-
Headquarters
South San Francisco, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Pliant Therapeutics Inc (PLRX)
What is the current share price of Pliant Therapeutics Inc (PLRX) Today?
The share price of Pliant Therapeutics Inc (PLRX) is $1.13 (NASDAQ) as of 28-Aug-2026 11:33 EDT. Pliant Therapeutics Inc (PLRX) has given a return of -58.89% in the last 3 years.
What is the current PB & PE ratio of Pliant Therapeutics Inc (PLRX)?
Since, TTM earnings of Pliant Therapeutics Inc (PLRX) is negative, P/E ratio is not available.
The P/B ratio of Pliant Therapeutics Inc (PLRX) is 0.48 times as on 21-Aug-2026, a 94 discount to its peers’ median range of 7.75 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.50 |
0.41 |
2024 |
-3.79 |
2.62 |
2023 |
-6.72 |
2.29 |
2022 |
-7.65 |
3.01 |
2021 |
-27.16 |
2.44 |
What is the 52 Week High and Low of Pliant Therapeutics Inc (PLRX)?
The 52-week high and low of Pliant Therapeutics Inc (PLRX) are Rs 1.95 and Rs 1.02 as of 28-Aug-2026.
What is the market cap of Pliant Therapeutics Inc (PLRX)?
Pliant Therapeutics Inc (PLRX) has a market capitalisation of $ 72 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pliant Therapeutics Inc (PLRX)?
Before investing in Pliant Therapeutics Inc (PLRX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.